Dublin, Feb. 25, 2019 (GLOBE NEWSWIRE) -- The "Global Neurodiagnostics Market Forecast up to 2025" report has been added to ResearchAndMarkets.com's offering.

The global neurodiagnostics market will grow at a CAGR of 7.5% during the forecast period

The market has witnessed steady growth in the past few years, and the development in technology with the introduction of advanced products has increased the acceptance of neurodiagnostics products in the market. The market is fueled by the growing adoption of novel diagnostics technologies, upsurge in the number of patients with neurological diseases, and increasing aging population.

Imaging and in vitro diagnostics are the most widely used technologies for the diagnosis of mental health disorders. This particular field is getting revolutionized with the advancement in technology. Globally, there are around dozens of 7-T machines in research labs, and the first 7-T model was cleared for clinical use in 2018. Vendors are focusing on new product launches and targeting toward end user's perspective. The revenue is generated from the key players operating in this field, and few of them include GE Healthcare, Philips Healthcare, Siemens Healthineers, Canon Medical Systems Corporation, Hitachi Medical Corporation, and Nihon Kohden Corporation.

According to the authors analysis, North America accounted for the largest share of the global neurodiagnostics market in 2018 and will retain a high position during the forecast period. The region has the highest percentage of the geriatric population with a growing prevalence of neural diseases such as Parkinson disease, epilepsy, migraine, and stroke. Further, the availability of advanced technologies is driving the market growth in North America. The Asia Pacific region is expected to witness the fastest growth rate due to the increasing patient pool, growing awareness among patients, and rising healthcare expenditure.

In 2018, the neuroimaging technologies segment occupied the largest share and is expected to remain the same during the forecast period. Among various neuroimaging technologies, CT and MRI are the two key imaging modalities commonly used to identify brain anomalies. The neuroinformatics segment is anticipated to grow at a high CAGR during the forecast period.

The market is dominated by North America, followed by Europe and Asia Pacific. The US occupied the dominant share in North America due to the rapid adoption of new and advanced diagnostic technologies.

Neurodiagnostics Market Research Competitive Analysis - The global neurodiagnostics market has massive growth opportunities in both developed and developing regions. The advancements and upgradation of technology will increase the competition among vendors. Many vendors are focusing on developing innovative products to strengthen their product portfolio that intensifies the market competition.

In January 2018, Brain Vision Solutions launched LiveAmp 64, a high-density wireless EEG solution that can be used with a wide range of innovative electrode technologies and also, there is an easy upgrade path all the way from 8 to 64 channels. Nihon Kohden launched its airEEG WEE-1200 wireless EEG system in March 2018, and it is designed specifically for patient comfort and easy access to real-time patient data during long-term epilepsy monitoring.

GE Healthcare introduced its range of MRI contrast media products with the launch of macrocyclic agent Clariscan in Europe in March 2017. Canon Medical Systems launched its next-generation 80-row multi-slice CT scanner, Aquilion Prime SP, at UKRC in 2017. The company has also initiated collaborative research in March 2018 on the application of Artificial Intelligence (AI)-based technology in MR imaging, together with Kumamoto University and the University of Bordeaux. In addition, other leading players are focusing on investing heavily in R&D activities to develop new products to attain a maximum share in the market.

The market is highly competitive with all the players competing to gain market shares. Intense competition, rapid advancements in technology, frequent changes in government policies, and the prices are key factors that confront the market.
The requirement of high initial investment, implementation, and maintenance cost in the market are also limiting the entry of new players.

Key Takeaways:

  • Understanding the potential market opportunity with precise market size and forecast data.
  • A detailed market analysis focusing on the growth of the neurodiagnostics industry.
  • Factors influencing the growth of the neurodiagnostics market.
  • In-depth competitive analysis of dominant and pure-play vendors.
  • Prediction analysis of the neurodiagnostics industry in both developed and developing regions.
  • Key insights related to major segments of the neurodiagnostics market.
  • The latest market trend analysis impacting the buying behavior of the consumers.

Key Topics Covered:

1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends

2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions

3 Market Snapshot
3.1 Market Definition
3.2 Types of Neurological Diseases
3.3 Causes of Neurological Diseases
3.4 Signs of Neurological Disorders
3.5 Distinctive Neurological Procedures
3.6 Segmented Addressable Market
3.7 Key Trends in the Neurodiagnostics Market
3.8 Related Markets
3.8.1 Parkinson's Diseases
3.8.2 Neurointerventional Devices
3.8.3 Neurosurgical Devices

4 Market Outlook
4.1 Market Segmentation
4.2 PEST Analysis
4.3 Porter 5(Five) Forces

5 Market Characteristics
5.1 DRO Analysis - Market Dynamics
5.1.1 Drivers Increasing number of patients with neurological diseases Increasing aging population Growing adoption of novel diagnostic technologies
5.1.2 Opportunities Upsurge in the introduction of new products and recent product approvals Advancement in technology
5.1.3 Restraints High cost of diagnosis Lack of trained professionals
5.2 DRO - Impact Analysis
5.3 Key Stakeholders

6 Technologies: Market Size and Analysis
6.1 Overview
6.2 Neuroimaging
6.2.1 Computed Tomography
6.2.2 Magnetic Resonance Imaging
6.2.3 Nuclear Medicine Imaging
6.2.4 Near Infrared Spectroscopic Imaging
6.2.5 Electroencephalography
6.2.6 Magnetoencephalography
6.2.7 Voxel-based Morphometry
6.3 In Vitro Diagnostics
6.4 Neuroinformatics

7 Regions: Market Size and Analysis
7.1 Overview
7.2 North America
7.3 Europe
7.4 Asia Pacific
7.5 Rest of the World

8 Competitive Landscape
8.1 Overview

9 Vendors Profile
9.1 GE Healthcare
9.2 Hitachi Medical Corporation
9.3 Siemens Healthineers
9.3.1 Overview
9.4 Philips Healthcare
9.5 Canon Medical Systems Corp.
9.6 Nihon Kohden Corporation

10 Companies to Watch For
10.1 Bruker Corporation
10.2 Fonar Corporation
10.3 NeuroNexus Technologies
10.4 Neusoft Medical Systems Co. Ltd.
10.5 Plexon Inc.
10.6 Lifelines Neurodiagnostics Systems Inc.
10.7 Natus Medical
10.8 NeuroDx Development

For more information about this report visit https://www.researchandmarkets.com/research/cmgrfj/global?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: In Vitro Diagnostics